Navigation Links
Neuro Kinetics Appoints Dr. Terri Ives Clinical Director, Audiology
Date:12/3/2007

PITTSBURGH, Dec. 3 /PRNewswire/ -- Neuro Kinetics, Inc. (http://www.neuro-kinetics.com), manufacturers of noninvasive medical diagnostic equipment used worldwide for balance, vestibular and neurological disorder tests, said today that Dr. Terri Ives has been appointed clinical director, audiology.

Ives will manage the company's clinical testing, coordination of multi- site research projects, clinical support, regulatory compliance and educational/training outreach programs for audiologists and other specialists. She also will be involved in new product development and research and will help represent the company with professional associations.

Earlier this year, Neuro Kinetics introduced its I-Portal(R)-VNG (Video Nystagmography System) and I-Portal(R)-Super VNG, designed for in-office early-screening balance and dizziness testing by audiologists, as well as otolaryngologists, neurologists and others. The company also manufactures other medical devices, including the Neuro-Otologic Test Center (NOTC) featuring its renowned barany (rotational) chair.

"We are delighted that Dr. Ives has opted to continue her distinguished career with our company," Howison Schroeder, Neuro Kinetics president and CEO, said. "Terri brings a tremendous depth of knowledge and expertise about audiology and diagnosis of disorders related to it. She also has a rare combination of perspectives from her work as a clinician, researcher, instructor, and executive in both academia and the medical equipment field. Terri will play a significant role for our company as we continue to expand our presence in the audiology market."

Said Ives, "I am excited by the opportunity to work with the highly skilled team at Neuro Kinetics. This company is on the move forward with amazing technological advances and I'm thrilled to be part of it."

Before joining Neuro Kinetics, Ives held a number of managerial and research positions at clinics, research facilities and medical firms. She was manager of clinical research at Sound ID in Palo Alto, California, and also was chief of audiology and director of the Balance Center at the Hearing Institute for Children and Adults in San Jose, California.

Ives also was director of diagnostic audiology at the California Ear Institute at Stanford in Palo Alto. She has served on various editorial, advisory and examination boards for such leading publications as Audiology Online and the American Academy of Audiology Vestibular Disorders Evaluation and Treatment Examination Committee.

A Fellow in the American Academy of Audiology and holding the Certificate of Clinical Competence in Audiology (CCC-A) by the American Speech-Language- Hearing Association, Ives has a Doctor of Audiology degree from the Pennsylvania College of Optometry's School of Audiology (where she also served as an assistant professor), both a Doctor of Science in Audiology and a Master of Audiology from Boston University, and a Bachelor of Science in Communication Disorders from Emerson College (with honors).

Ives, originally born in Cheyenne, Wyoming, and raised on the family homestead ranch near Rozet, Wyoming, now lives in the Denver area. Her husband, Phillip Ives, Au.D., is the manager of issue tracking with Advanced Bionics Corporation. They have four children.

For more information about Neuro Kinetics, please visit its Web site (http://www.neuro-kinetics.com) or contact the company in the U.S. +1.412.963.6649 or via e-mail to info@neuro-kinetics.com.

MEDIA CONTACT

John Buckman

Buckman Communications, for Neuro-Kinetics, Inc.

+ 1 412-381-2900 or jbuckman@buckman.biz


'/>"/>
SOURCE Neuro Kinetics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
2. New research shows how chronic stress worsens neurodegenerative disease course
3. NYU study points to lasting impact of mild hearing loss on neurological processes
4. Low level of neuronal receptor linked to mild cognitive impairment and Alzheimers disease
5. Special Conference: Women and Neurological Diseases
6. Neurobiological Technologies Reports Going Concern Qualification
7. Brandeis neuroscientist wins NIH directors Pioneer Award
8. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
9. Kids Vaccine Ingredient Not Likely Linked to Neurological Problems
10. Loss of gene leads to protein splicing and buildup of toxic proteins in neurons
11. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: